ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,150Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 656

$2.15M Total Retail Price of All Prescriptions

Rank: 4 out of 656

660 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

10% of this provider’s 2,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$164 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
ZOLPIDEM TARTRATE 1,743 297 10 1 3
RISPERIDONE 770 257 2 2
ABILIFY 584 86 3 6
TRAZODONE HCL 552 94 4 1
BENZTROPINE MESYLATE 535 104 R 5 4
DIVALPROEX SODIUM ER 495 82 6 10
TRIHEXYPHENIDYL HCL 473 98 R 10 7 54
SERTRALINE HCL 435 91 8 8
SEROQUEL XR 424 72 9 21
QUETIAPINE FUMARATE 414 98 10 5
ESCITALOPRAM OXALATE 356 70 11 18
CITALOPRAM HBR 334 46 12 9
CYMBALTA 327 52 13 7
FLUOXETINE HCL 291 53 14 11
PRISTIQ ER 275 56 15 30
OLANZAPINE 274 51 16 12
BUSPIRONE HCL 254 35 17 19
SEROQUEL 233 48 18 20
BUPROPION XL 226 0 19 17
HALOPERIDOL DECANOATE 203 38 20 62
ZIPRASIDONE HCL 200 21 21 27
DONEPEZIL HCL 183 150 22 33
LUNESTA 171 47 23 51
VENLAFAXINE HCL ER 158 0 24 15
MIRTAZAPINE 156 52 25 13
LITHIUM CARBONATE 151 0 26 16
PAROXETINE HCL 145 14 27 23
INVEGA SUSTENNA 134 16 28 39
HALOPERIDOL 132 36 29 26
INVEGA 129 0 30 38
TOPIRAMATE 124 0 31 34
CLOZAPINE 124 0 31 31
LAMOTRIGINE 122 13 33 14
LEXAPRO 115 21 34 47
DOXEPIN HCL 104 0 35 41
DIVALPROEX SODIUM 99 31 36 24
NAMENDA 98 78 37 22
PROPRANOLOL HCL 92 0 38 49
GABAPENTIN 84 15 39 29
LATUDA 82 0 40 46
RISPERDAL CONSTA 70 17 41 40
OXCARBAZEPINE 69 12 42 28
CARBAMAZEPINE 68 17 43 35
BUPROPION HCL SR 64 20 44 25
ZOLPIDEM TARTRATE ER 61 13 45 76
GEODON 55 0 46 57
THIORIDAZINE HCL 54 24 R 47 93
CHLORPROMAZINE HCL 53 24 48 55
ZYPREXA 53 11 48 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.